Mahar, E., Sprenger, R., Diesing, J., Kossack, N., Häckl, D. & Eiff, C. von. (2022).
Case Fatality Risk and Attributable Costs in Patients Treated for Community-Acquired Pneumonia in Germany: A Population-Based Healthcare Claims Data Cohort Study. [preprint].
SSRN Electronic Journal.
DOI:https://doi.org/10.2139/ssrn.4118607 (abgerufen am 30.10.2023).
Therapy areas:
Respiratory
Indications:
Pneumonia
Cardiorenal Risk with Sodium‐Glucose Cotransporter‐2 Inhibitors versus Dipeptidyl Peptidase‐4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study;
Diabetes, Obesity and Metabolism, 2020
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
Cardiorenal Risk with SGLT2i versus DPP4i in T2D Patients without Established Cardiovascular- and Renal Diseases: A Large Multinational Observational Study
ASN Congress
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
Requena G, Rothnie K, Noorduyn SG, Claussen J, Schultze M, Kossack N, Richter L, Vogelmeier C, Beeh KM, Sharma R, Compton C, Ismaila A.
Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions.
Value in Health, Volume 26, Issue 11, S2 (December 2023).
No DOI/URL available
Therapy areas:
Respiratory
Indications:
COPD
Garcia, T. B., Kliemt, R., Claus, F., Neumann, A., Soltmann, B., Baum, F., Schwarz, J., Swart, E., Schmitt, J., Pfennig, A., Häckl, D. & Weinhold, I. (2023).
Agreement between self-reports and statutory health insurance claims data on healthcare utilization in patients with mental disorders.
BMC Health Services Research, 23(1), S. 1243.
DOI:https://doi.org/10.1186/s12913-023-10175-6 (abgerufen am 03.01.2024).
Therapy areas:
Psychiatry
Indications:
Mental disorder
Otto, T., Diesing, J., Borchert, J., Heitmann, E., Schloot, N., Lebrec, J., Müller-Wieland, D. & Häckl, D. (2023).
Age-dependent prevalence of type 2 diabetes, cardiovascular risk profiles, and use of diabetes drugs in Germany using health claims data.
Diabetes Obes Metab. (Diabetes, Obesity and Metabolism), 25(3), S. 767–775.
DOI:https://doi.org/10.1111/dom.14924 (abgerufen am 30.10.2023).
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
Requena, G., Rothnie, K. J., Noorduyn, S. G., Claussen, J., Schultze, M., Kossack, N., Richter, L. M., Vogelmeier, C. F., Beeh, K.-M., Sharma, R., Compton, C. & Ismaila, A. S. (2023).
Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions. [Vortrag].
ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen.
Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3788/131191 (abgerufen am 03.01.2024).
Therapy areas:
Respiratory
Indications:
COPD
Farbod Sedaghat-Hamedani, Carla Zema, Michael Schultze, Tarcyane Garcia, Nils Kossack, Ervant Maksabedian Hernandez, Tobias Bluhmki, Taryn Krause, Johanna Schmoelders, Benjamin Meder.
Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany.
European Society of Cardiology (ESC) Congress 2024, 30 August – 02 September 2022, London.
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Cardiomyopathy